NSCLC: Immune-related AEs during checkpoint inhibitor therapy may predict outcomesJune 6, 2021Lung CancerOncology
Elevated factor VIII troughs can lead to a higher proportion of zero bleeds in hemophiliaJune 1, 2021Oncology
Racial and ethnic minorities underrepresented in pancreatic cancer clinical trialsMay 27, 2021Oncology
FDA OKs nivolumab after surgery for esophageal or GEJ cancer: Practice-changing use of immunotherapyMay 24, 2021Oncology
Telemedicine is popular among Mohs surgeons – for nowMay 17, 2021MelanomaOncologyBusiness of Medicine
BERENICE: Further evidence of heart safety of dual HER2 blockadeMay 13, 2021Breast CancerOncologyWomen's Health
Esophageal cancer: Preoperative chemoradiotherapy benefit in CROSS persists over 10 yearsMay 12, 2021Oncology
Delayed Coronary Vasospasm in a Patient with Metastatic Gastric Cancer Receiving FOLFOX TherapyMay 12, 2021Genitourinary CancerOncology
Standardization of the Discharge Process for Inpatient Hematology and Oncology Using Plan-Do-Study-Act Methodology Improves Follow-Up and Patient Hand-OffMay 12, 2021Oncology
Factors Associated with Radiation Toxicity and Survival in Patients with Presumed Early-Stage Non-Small Cell Lung Cancer Receiving Empiric Stereotactic Ablative RadiotherapyMay 12, 2021Lung CancerOncology
